Results 1 to 10 of about 16,274 (194)
Journal of Medical Microbiology and Infectious Diseases, 2022 Introduction: In HIV-associated tuberculosis cases, identifying nontuberculous Mycobacteria (NTM) from clinical samples has become essential regarding patients’ treatment and prognosis.
Soumya Dasgupta1, Oindrila Chakraborty2
doaj +1 more source
Micobacterii netuberculoase şi bronşiectazii
Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2021 Bolile pulmonare cauzate de micobacterii netuberculoase au devenit o problemă multidisciplinară emergentă în ultimele decenii, în pofida lipsei datelor epidemiologice în mai multe ţări, inclusiv şi în Republica Moldova.
Oxana Munteanu, Victor Botnaru
doaj +1 more source
Antibiotics, 2020 Clarithromycin (CLR) is the corner stone in regimens for the treatment of lung disease caused by Mycobacterium abscessus (Mab). However, many strains harbor the CLR-inducible CLR resistance gene erm41, encoding a ribosome methylase. Induction of erm41 is
Dinah Binte Aziz +2 more
doaj +1 more source
Microorganisms, 2020 Bacille Calmette−Guerin (BCG) vaccination is widely practiced around the world to protect against the mycobacterial infection tuberculosis. BCG is also effective against the pathogenic mycobacteria that cause leprosy and Buruli’s ulcer.
Coad Thomas Dow
doaj +1 more source
Diagnostics, 2022 The aim of this study is to determine the cumulative incidence of, and the risk factors for, the development of nontuberculous mycobacteria pulmonary disease (NTM-PD) following lung cancer surgery. We retrospectively analyzed patients with non-small cell
Bo-Guen Kim +10 more
doaj +1 more source
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
ERJ Open Research, 2022 Background Although interest in nontuberculous mycobacteria (NTM) infection has increased in the last decades, published data vary according to different geographical areas, diagnostic facilities and quality of study design.
Kseniia Suska +10 more
doaj +1 more source
Scientific Reports, 2021 Microbiological criteria for nontuberculous mycobacterial pulmonary disease (NTM-PD) require cultures from two separate sputum or one non-sputum specimen.
Sooim Sin +7 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 Non-tuberculous mycobacteria (NTM) are opportunistic pathogens that can infect all body tissues and organs. In particular, the lungs are the most commonly involved organ, with NTM pulmonary diseases causing serious health issues in patients with ...
Yuzhen Gu +3 more
doaj +1 more source
Frontiers in Microbiology, 2022 BackgroundThe prevalence of nontuberculous mycobacteria (NTM) in patients with chronic respiratory disease has increased. The implication of NTM in non-CF bronchiectasis remained controversial.
Chun-Yu Lin +18 more
doaj +1 more source
Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review
Journal of the Formosan Medical Association, 2020 Nontuberculous mycobacteria (NTM) are critical emerging global infectious pathogens. Though NTM can be mere colonizers when isolated from human specimens, NTM are also responsible for diverse human infections. NTM–lung disease (NTM-LD) is the most common
Meng-Rui Lee +4 more
doaj +1 more source